These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

79 related articles for article (PubMed ID: 4022377)

  • 1. Opiate antagonist WIN44,441-3 stereospecifically improves neurologic recovery after ischemic spinal injury.
    Faden AI; Jacobs TP
    Neurology; 1985 Sep; 35(9):1311-5. PubMed ID: 4022377
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Motor dysfunction after spinal cord injury is mediated by opiate receptors.
    Faden AI; Knoblach S; Mays C; Jacobs TP
    Peptides; 1985; 6 Suppl 1():15-7. PubMed ID: 2995941
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Naloxone in experimental spinal cord ischemia: dose-response studies.
    Faden AI; Jacobs TP; Smith MT; Zivin JA
    Eur J Pharmacol; 1984 Aug; 103(1-2):115-20. PubMed ID: 6479224
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Role of thyrotropin-releasing hormone and opiate receptor antagonists in limiting central nervous system injury.
    Faden AI
    Adv Neurol; 1988; 47():531-46. PubMed ID: 2830771
    [TBL] [Abstract][Full Text] [Related]  

  • 5. New pharmacologic approaches to spinal cord injury: opiate antagonists and thyrotropin-releasing hormone.
    Faden AI
    Cent Nerv Syst Trauma; 1985; 2(1):5-8. PubMed ID: 3004747
    [No Abstract]   [Full Text] [Related]  

  • 6. Comparison of the neuroprotective effects of the N-methyl-D-aspartate antagonist MK-801 and the opiate-receptor antagonist nalmefene in experimental spinal cord ischemia.
    Yum SW; Faden AI
    Arch Neurol; 1990 Mar; 47(3):277-81. PubMed ID: 2178593
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Opiate-receptor antagonist nalmefene improves neurological recovery after traumatic spinal cord injury in rats through a central mechanism.
    Faden AI; Sacksen I; Noble LJ
    J Pharmacol Exp Ther; 1988 May; 245(2):742-8. PubMed ID: 3367315
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Treatment of experimental stroke with the opiate antagonist win 44,441-3 effects on neurologic function, infarct size, and survival.
    Baskin DS; Hosobuchi Y
    NIDA Res Monogr; 1986; 75():531-4. PubMed ID: 3123973
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Opiate antagonist improves neurologic recovery after spinal injury.
    Faden AI; Jacobs TP; Holaday JW
    Science; 1981 Jan; 211(4481):493-4. PubMed ID: 7455690
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of the calcium channel antagonist nimodipine in experimental spinal cord ischemia.
    Faden AI; Jacobs TP; Smith MT
    J Neurosurg; 1984 Apr; 60(4):796-9. PubMed ID: 6707749
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Kappa-selective opiate antagonist nor-binaltorphimine improves outcome after traumatic spinal cord injury in rats.
    Faden AI; Takemori AE; Portoghese PS
    Cent Nerv Syst Trauma; 1987; 4(4):227-37. PubMed ID: 3446373
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Limiting ischemic spinal cord injury using a free radical scavenger 21-aminosteroid and/or cerebrospinal fluid drainage.
    Francel PC; Long BA; Malik JM; Tribble C; Jane JA; Kron IL
    J Neurosurg; 1993 Nov; 79(5):742-51. PubMed ID: 8410254
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Neuropeptides in spinal cord injury: comparative experimental models.
    Faden AI; Jacobs TP; Smith GP; Green B; Zivin JA
    Peptides; 1983; 4(5):631-4. PubMed ID: 6657511
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Levels of endogenous opioids and effects of an opiate antagonist during regional cerebral ischemia in rats.
    Andrews BT; McIntosh TK; Gonzales MF; Weinstein PR; Faden AI
    J Pharmacol Exp Ther; 1988 Dec; 247(3):1248-54. PubMed ID: 3204516
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Neuropeptides and central nervous system injury. Clinical implications.
    Faden AI
    Arch Neurol; 1986 May; 43(5):501-4. PubMed ID: 2870700
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Endogenous opioids may mediate secondary damage after experimental brain injury.
    McIntosh TK; Hayes RL; DeWitt DS; Agura V; Faden AI
    Am J Physiol; 1987 Nov; 253(5 Pt 1):E565-74. PubMed ID: 2891303
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Intrathecal transplantation of bone marrow stromal cells attenuates blood-spinal cord barrier disruption induced by spinal cord ischemia-reperfusion injury in rabbits.
    Fang B; Wang H; Sun XJ; Li XQ; Ai CY; Tan WF; White PF; Ma H
    J Vasc Surg; 2013 Oct; 58(4):1043-52. PubMed ID: 23478501
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Opiate-receptor antagonists, thyrotropin-releasing hormone (TRH), and TRH analogs in the treatment of spinal cord injury.
    Faden AI
    Cent Nerv Syst Trauma; 1987; 4(4):217-26. PubMed ID: 3128405
    [No Abstract]   [Full Text] [Related]  

  • 19. Experimental CNS ischemia: serotonin antagonists reduce or prevent damage.
    Zivin JA; Venditto JA
    Neurology; 1984 Apr; 34(4):469-74. PubMed ID: 6142430
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The AMPA antagonist LY293558 improves functional neurological outcome following reversible spinal cord ischemia in rabbits.
    Bowes MP; Swanson S; Zivin JA
    J Cereb Blood Flow Metab; 1996 Sep; 16(5):967-72. PubMed ID: 8784241
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.